Company intelligence / Profile preview

Tramway Venture Partners

Albuquerque, New Mexico, United States

Ownership: Private
Development stage: Other

Overview

Tramway Venture Partners is an active, early-stage venture fund investing in promising biotech, medtech, and healthtech startups, primarily in North America with a focus on companies with disruptive technologies and significant market potential. Recent funded portfolio companies include Circular Genomics (circRNA diagnostics for psychiatric and neurological disorders).

Industry: Investors

Partnerships

Circular Genomics (co-investment with Cottonwood Technology Fund, Mountain Group Partners)

Beyond the preview

Go deeper on Tramway Venture Partners.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Tramway Venture Partners.

Explore the full profile